Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
J Cell Physiol ; 234(9): 14927-14940, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30811030

ABSTRACT

The increasing rate of mortality and morbidity because of cardiac diseases has called for efficient therapeutic needs. With the advancement in cell-based therapies, stem cells are abundantly studied in this area. Nearly, all sources of stem cells are experimented to treat cardiac injuries. Tissue engineering has also backed this technique by providing an advantageous platform to improve stem cell therapy. After in vitro studies, primary treatment-based research studies comprise small and large animal studies. Furthermore, these studies are implemented in human models in the form of clinical trials. Purpose of this review is to highlight the animal- and human-based studies, exploiting various stem cell sources, to treat cardiovascular disorders.

2.
Biotechnol Appl Biochem ; 66(4): 478-483, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30953379

ABSTRACT

Nanofibrous scaffolds have potential to improve coronary stent applications by promoting endothelial recovery on the stent surface and aids regeneration of cardiac tissues. Presently, scaffolds fabricated via electro-spinning are been widely used because of their ability to bio-mimic the precise anatomical structure of the protein fibers. Properties like convenience to spin on several components and functionalization with several bioactive molecules have signify the use of nanofibrous scaffolds for tissue engineering. This review highlights some recent applications of electrospun nanofibrous scaffolds in the treatment and management of cardiac arterial diseases and engineering new cardiac tissues.


Subject(s)
Coronary Artery Disease/drug therapy , Coronary Artery Disease/prevention & control , Nanofibers/chemistry , Tissue Scaffolds/chemistry , Humans , Tissue Engineering
3.
Health Sci Rep ; 7(5): e2057, 2024 May.
Article in English | MEDLINE | ID: mdl-38736476

ABSTRACT

Background and Aim: One of the complications of using catheters is the occurrence of thrombosis, which can be dangerous for patients. The main objective of this study is to compare the effect of heparin, reteplase, and taurolock in the prevention of thrombosis in hemodialysis catheters. Methods: The present study is a clinical trial, in which the effect of three drugs, heparin, reteplase, and taurolock, in the prevention of thrombosis in hemodialysis catheters, has been investigated. The research units were studied in two intervention and control groups. The stratified random allocation method was used to assign patients to five groups (control, Heparin 50, Heparin 1000, reteplase, and taurolock), with strata based on the patient's age (20-70 years), gender, and duration of dialysis. Within each stratum, patients were also assigned to groups using the randomized block permutation method and a random number table tool. To prevent bias, this study is triple-blinded. This means that the patient, the thrombosis assessor, and the statistical analyst are unaware of the type of intervention received by the patient. Results: Gender (p < 0.999), age distribution (p = 0.774), and duration of dialysis (p = 0.875) showed no statistically significant relationship with thrombosis. However, significant differences were observed among the five groups regarding thrombosis incidence. The relative risk of thrombosis in the Heparin 50, Heparin 1000, reteplase, and taurolock groups compared to the control group was 92.5%, 92.2%, 98.2%, and 89% lower, respectively. Conclusion: Our study underscores the efficacy of heparin, reteplase, and taurolock in preventing thrombosis in hemodialysis catheters. While all three drugs demonstrated efficacy, the Heparin 50 group exhibited the highest relative risk reduction. These findings suggest that heparin, particularly at a low dose, should be considered a standard prophylactic treatment in hemodialysis patients.

4.
Ann Med Surg (Lond) ; 79: 104016, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35860151

ABSTRACT

Objective: Cholecystectomy is a gold-standard procedure for symptomatic gallbladder stones. However, dyslipidemia is reported in about 50% of these patients. The aim of this study is to evaluate the change in the levels of total cholesterol following cholecystectomy. Methods: In this cross-sectional study, patients who underwent cholecystectomy for gallstone in (XXX) Nursing Home were included. Preoperative cholesterol levels and those following a month of the surgery were measured in the patients. A form, comprising of the demographic details, along with clinical outcomes was prepared for each patient and the data were analyzed using SPSS v25.0 software. Results: 33 patients were included in this study, of which 29 were females and 4 were males. 48.5% of our patient's population were aged above 50 years. The mean of preoperative cholesterol levels was 203.78 mg/dL. One month after the surgery, the mean cholesterol level was found to be 197.03 mg/dL. Overall, there was no statistical difference between the preoperative and one-month postoperative cholesterol level. Conclusion: Our patients did not present hypercholesterolemia with gallstone disease. Furthermore, one month after the surgical intervention (Cholecystectomy), we did not find any significant changes in the cholesterol levels. Detailed investigation of complete lipid profile with long-term follow up in a larger population is thereby required.

5.
Ann Med Surg (Lond) ; 62: 469-472, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33604034

ABSTRACT

BACKGROUND: Voice changes are common complaint following thyroidectomy that might or might not be associated with laryngeal nerve damage. Objective: The aim of this study is to evaluate the effect thyroidectomy on voice alteration and its association with gender and age. METHODS: In this descriptive analytical study, patients who underwent thyroidectomy at (XXX) without laryngeal nerve damage were included. These patients were evaluated based on subjective (self-reported) and objective (videostroboscopy) voice assessment. The data was collected immediately after the surgery and 6 months after the surgery during the follow-up. RESULTS: Of 76 patients included, the mean age of patients was 46.3 year. 25 (43.4%) were males and 51 (56.6%) were female. 28.9% patients were presented with apparent damage to the vocal cords, of which 8 (10.5) had voice changes. There was no statistically significant difference between sex and postoperative vocal cord dysfunction (P = 0.592). However, in male gender, late postoperative voice changes were significantly more, p = 0.013. The age was also not associated with immediate or late postoperative changes and damage to vocal cords, p > 0.05. CONCLUSION: Our study reported that male gender can be an important factor in deterring voice changes after thyroidectomy nonetheless, it can not predict the risk of vocal cord damage. Furthermore, age might not a risk factor either. Studies with greater sample size are required to confirm these findings.

6.
Curr Med Imaging ; 17(5): 608-612, 2021.
Article in English | MEDLINE | ID: mdl-33213335

ABSTRACT

BACKGROUND: Hyperthyroidism is a common systemic disorder where Graves' disease is known as the leading cause of the disease. Thyroid stimulating hormone, T4 and T3 antibody assay is usually performed for the diagnosis of the pathology. However, with uncertainty in the results and in order to estimate the magnitude and the exact cause of the disease, radioactive iodine uptake (RAIU) test is recommended. The aim of this study is to evaluate underlying pathology in the patients presenting hyperthyroidism using RAIU test results. METHODS: This is a cross-sectional retrospective study conducted on the patients with hyperthyroidism referred to Shahid Madani Hospital in Khorramabad. Data regarding the biochemical analysis and RAIU test was collected from the records and a questionnaire based on demographic and clinical information was completed for each patient. RESULTS: Of 137 patients presenting hyperthyroidism, 62.04% presented with Graves' disease, 24.08% with toxic multinodular goiter and 13.86% with toxic adenoma. 24-hour RAIU test showed that the percent of radioiodine uptake was most in toxic adenoma with 67.7%, Graves' disease 53.5% and multinodular goiter 39%, respectively. From the age-based analysis, we found that Graves' was most common in 20-30 years old individuals accounting for 34%, multinodular goiter in 50+ aged individuals with 36.3% and toxic adenoma was most prevalent in 30-40 and 50+ aged patients, with 26.3%. In our population of interest, 81.8% toxic multinodular goiter patients were females. CONCLUSION: Our study presents the outcome of RAIU tests in hyperthyroidism based on the underlying pathologies. We also conclude, in light of other findings, that Graves' disease is the most common cause of hyperthyroidism in our population.


Subject(s)
Hyperthyroidism , Thyroid Neoplasms , Adult , Aged , Cross-Sectional Studies , Female , Humans , Hyperthyroidism/epidemiology , Iodine Radioisotopes , Retrospective Studies , Tomography, X-Ray Computed , Young Adult
7.
Ann Med Surg (Lond) ; 72: 103146, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34925825

ABSTRACT

BACKGROUND: Peripheral artery disease (PAD) is a cardiovascular disease that is characterized by obstruction of peripheral artery. It is associated with comorbidities, reduced quality of life and mortality. The aim of this study was to determine the frequency of recurrence of PAD among patients who underwent angioplasty or stenting and associated risk factors. METHODS: In this retrospective study, all patients referred to the cardiovascular center of (XXX) with the diagnosis of lower extremity PAD were included. Patients' demographic information, age, gender, smoking status, history of diabetes, history of hypertension, dyslipidemia, number of vessels, type of stent, recurrence of the disease, and size of the lesion were obtained from the hospital database. Endovascular revascularization therapy was either performed by angioplasty or stenting method. The data were analyzed by SPSS v21. RESULTS: Of 88 patients included in this study, 12.5% were reported with restenosis. Gender, age, size of the lesion, the status of smoking, history of hypertension, and dyslipidemia were not significantly associated with the recurrence of stenosis, p > 0.05. There was a significant relationship between the vessels involved and the type of revascularization method and the recurrence of the PAD. CONCLUSION: Endovascular revascularization technique and type of vessel involved in PAD are significant factors contributing to restenosis in our population of study. However, further studies with a greater sample size are required in this area.

8.
Open Access Emerg Med ; 12: 255-260, 2020.
Article in English | MEDLINE | ID: mdl-33116961

ABSTRACT

OBJECTIVE: Laparotomy is commonly indicated in patients presenting blunt or penetrating trauma. This cross-sectional study is designed to evaluate the frequency and the causes of laparotomy following abdominal trauma. MATERIALS AND METHODS: The data of 71 patients who underwent laparotomy as a result of abdominal trauma in Shohada Ashayer Hospital, Khorramabad were evaluated and a questionnaire was completed for each patient. All the data were analyzed statistically using SPSS. RESULTS: Of 71 patients, 61 underwent positive laparotomy whereas, negative laparotomy was performed in 10 patients. The results from this study showed that the most common organ of the injury was spleen (19.7%), followed by other solid organs. The small intestine (16.4%) was found more prone to injuries in penetrating trauma. Incidence of blunt trauma injury due to road accidents was the greatest 50.82% and 20% of penetrating traumas were the result of a firearm. CONCLUSION: Abdominal trauma injury is common in our study population where spleen, small intestine and other solid organs are chiefly involved. Indications of laparotomy should be fully examined in order to avoid negative laparotomies and associated complications.

9.
Article in English | MEDLINE | ID: mdl-33001020

ABSTRACT

Cardiac arrhythmias are associated with several cardiac diseases and are prevalent in people with or without structural and valvular abnormalities. Ventricular arrhythmias (VA) can be life threating and their onset require immediate medical attention. Similarly, atrial fibrillation and flutter lead to stroke, heart failure and even death. Optimal treatment of VA is variable and depends on the medical condition associated with the rhythm disorder (which includes reversible causes such as myocardial ischemia or pro-arrhythmic drugs). While an implanted cardioverter defibrillator is often indicated in secondary prevention of VA. This review highlights the newest advancements in these techniques and management of ventricular and atrial tachyarrhythmias, along with pharmacological therapy.


Subject(s)
Atrial Fibrillation/therapy , Tachycardia, Ventricular/therapy , Animals , Atrial Fibrillation/pathology , Cardiac Resynchronization Therapy , Defibrillators, Implantable , Disease Management , Humans , Tachycardia, Ventricular/pathology , Treatment Outcome
10.
Future Cardiol ; 16(6): 675-685, 2020 11.
Article in English | MEDLINE | ID: mdl-32643391

ABSTRACT

Coronary artery bypass graft is one of the extensively conducted procedures to release occlusion in the coronary vessel. Various biological grafts are used for this purpose, superiorly, saphenous vein graft, if unavailable, other vessels in the body, with likewise characteristics are exploited for the purpose. The choice of graft is yet under discovery that could impeccably meet all the requirements. Variation in perioperative and postoperative results have given uneven clinical inferences of these conduits. Alternatively, tissue-engineering is also being applied in this area for clinical improvements. This review underlines some of the commonly used grafts for coronary artery bypass graft and advancements in tissue engineering for this purpose.


Subject(s)
Saphenous Vein , Tissue Engineering , Coronary Angiography , Coronary Artery Bypass , Humans , Saphenous Vein/surgery , Vascular Patency
11.
Article in English | MEDLINE | ID: mdl-32646364

ABSTRACT

BACKGROUND: Acute coronary syndrome (ACS) is one of the leading causes of mortality worldwide and is characterized by unstable angina or acute myocardial infarction. The aim of this study is to evaluate the clinical characteristics of patients who died of ACS. METHODS: In this cross-sectional study, 1000 patients presenting ACS were included. Data and records of these patients were evaluated for parameters such as; deceased status, age, gender, diagnosis, ECG, common complaints, associated risk factors, Killip class, pulse, blood pressure, geographic setup (urban or rural), complications and season in which the disease was presented. Statistical analysis was performed on the data obtained using SPSS-win software. RESULTS: The mortality rate among ACS patients in our study was 7.1%. Of these patients, AMI was the most prevalent diagnosis and chest pain was the most common complaint. Furthermore, low blood pressure, advanced age, increased pulse rate and fall/winter season were associated with the increased risk of mortality. ST deviation was the most seen ECG finding and most of the mortalities were within the 24 hours of admission. CONCLUSION: Our study reports risk factors associated with mortality in ACS patients. Advanced and timely therapeutic measurements are likely to reduce the incidence of mortality in these patients.


Subject(s)
Acute Coronary Syndrome/mortality , Acute Coronary Syndrome/complications , Acute Coronary Syndrome/physiopathology , Adult , Age Factors , Aged , Blood Pressure , Chest Pain/complications , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Mortality , Myocardial Infarction/complications , Risk Factors
12.
Future Cardiol ; 16(5): 481-496, 2020 09.
Article in English | MEDLINE | ID: mdl-32495650

ABSTRACT

Coronary artery disease is one of the commonest surgery demanding cardiovascular diseases. Coronary artery bypass graft surgery is practiced all over the world for the treatment of coronary artery disease. Systemic trauma during the surgery is associated with a wide range of complications, some of which are fatal. Preoperative risk factors such as age, previous illness and obesity are common predictors of these adverse events. Advances in therapeutic medicine have allowed timely treatment of these adverse events and co-morbidities. This review summarizes some of the most occurring complications associated with coronary artery bypass graft and corresponding treatment options.


Subject(s)
Cardiovascular Diseases , Coronary Artery Disease , Coronary Artery Bypass , Coronary Artery Disease/surgery , Humans , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/therapy , Risk Factors
13.
Clin Case Rep ; 8(4): 606-611, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32274020

ABSTRACT

We report a case of a geriatric patient who underwent CABG and developed sigmoid volvulus (SV) with recurrence. SV is a rarely reported complication of CABG. Timely diagnosis, management, and follow-up are strictly advised, particularly in geriatric patients. Immediate surgical measures are required to prevent volvulus-associated ischemia.

14.
J Complement Integr Med ; 16(4)2019 Aug 21.
Article in English | MEDLINE | ID: mdl-31433781

ABSTRACT

Background Fatigue is a common compliant among patients who undergo coronary artery bypass graft (CABG) surgery. This may affect patients' function in all aspects. A few studies have already assessed the influence of complementary therapies on minimizing fatigue. This study aimed to investigate the combined effect of vitamin C and omega-3 polyunsaturated fatty acids (n-3 PUFA) on fatigue following CABG surgery. Methods In this randomized, triple-blind placebo-controlled trial, 160 patients who already underwent CABG surgery were randomly assigned into an experimental or a control groups. Each group consisted of 80 patients. The experimental group was given both n-3 PUFA and vitamin C the day before surgery. They also received the same supplements in the first 5 days of operation. The control group received only placebo. Subjects in both groups responded to Multidimensional Fatigue Inventory (MFI-20) scale in the beginning, and at the end of the intervention as well as on the fifth day of the operation. Chi-square test and independent t-test were used for data analysis. Results The mean fatigue score in experimental and control groups came up to 62.01 ± 4.06 and 67.92 ± 4.95 (p<0.0001), respectively, which was greater than that of the values we had before intervention. The mean difference of fatigue score was 3.97 ± 3.49 and 9.56 ± 6.41 (p<0.0001) prior and following the intervention, correspondingly. Conclusion Combination of vitamin C and n-3 PUFA effectively reduces post-operative fatigue among patients who undergo CABG surgery.


Subject(s)
Ascorbic Acid/therapeutic use , Coronary Artery Bypass , Fatigue/drug therapy , Fatty Acids, Omega-3/therapeutic use , Aged , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Surveys and Questionnaires
15.
Tanaffos ; 17(1): 29-36, 2018 Jan.
Article in English | MEDLINE | ID: mdl-30116276

ABSTRACT

BACKGROUND: Chest tube removal is considered a painful technique, which may not respond well to palliative therapies. There are no standard procedures or guidelines to manage the pain associated with chest tube removal. This study aimed to examine the effects of cold application on pain reduction during and after chest tube removal. MATERIALS AND METHODS: This randomized controlled trial was conducted on 90 hospitalized patients, undergoing heart bypass surgery at the intensive care units where at least a pleural chest tube was inserted. The patients were randomly divided into two groups (45 samples per group). In the cold application group, an ice bag was placed at the designated point for 20 minutes before chest tube removal, while only routine interventions were applied for chest tube removal in the control group. Pain severity was measured in the groups before, during, and 15 minutes after chest tube removal, using the visual analogue scale. Repeated measures ANOVA test was applied for data analysis. RESULTS: There was no significant difference in the baseline pain score between the groups (P= 0.18). However, there was a significant difference in terms of pain severity score between the cold application (3.58±1.09) and control (4.73±0.86) groups during chest tube removal (P< 0.001). On the other hand, there was no significant difference between the groups regarding the score of pain severity at 15 minutes after chest tube removal (P= 0.38). CONCLUSION: Cold application, as a nonpharmacological intervention, may contribute to the alleviation of cryotherapy-related pain.

16.
J Clin Pathol ; 67(9): 828-31, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24964361

ABSTRACT

INTRODUCTION: Solitary osseous plasmacytoma rarely involves the distal extremities. We report a case and provide a brief review of the relevant literature. CASE PRESENTATION: We report a 64-year-old man who presented with swelling, mild pain and a deformed right index finger. The workup led to the diagnosis of solitary osseous plasmacytoma and the patient eventually required amputation of his finger. With clinical follow-up, the disease spread to regional lymph nodes and subsequently the patient developed systemic involvement and received chemotherapy. CONCLUSIONS: Solitary osseous plasmacytoma should be considered in the differential diagnosis of distal extremity neoplasms.


Subject(s)
Bone Neoplasms/pathology , Finger Phalanges/pathology , Plasmacytoma/pathology , Amputation, Surgical , Biomarkers, Tumor/analysis , Biopsy, Fine-Needle , Bone Neoplasms/chemistry , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/surgery , Finger Phalanges/chemistry , Finger Phalanges/diagnostic imaging , Finger Phalanges/surgery , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Male , Middle Aged , Plasmacytoma/chemistry , Plasmacytoma/diagnostic imaging , Plasmacytoma/surgery , Radiography , Radionuclide Imaging , Radiopharmaceuticals , Radiotherapy, Adjuvant , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL